Notification Rates of New HIV Diagnoses Up in Older Adults

This article originally appeared here.
Share this content:
Notification Rates of New HIV Diagnoses Up in Older Adults
Notification Rates of New HIV Diagnoses Up in Older Adults

WEDNESDAY, Sept. 27, 2017 (HealthDay News) -- Notification rates of new HIV diagnoses in older adults increased in 16 European countries from 2004 to 2015, according to a study published online Sept. 26 in The Lancet HIV.

Lara Tavoschi, Ph.D., from the European Centre for Disease Prevention and Control in Sweden, and colleagues compared data from older (aged ≥50 years) and younger (aged 15 to 49 years) people to examine factors associated with HIV diagnosis in 31 European Union (EU) and European Economic Area (EEA) countries between Jan. 1, 2004, and Dec. 31, 2015.

The researchers found that there were 54,102 new HIV diagnoses reported in older adults. Across the 12-year period, the average notification rate of new diagnoses was 2.6 per 100,000 population, which increased significantly over time (annual average change, 2.1 percent). In 16 countries, notification rates for new HIV diagnoses in older adults increased significantly, clustering in central and eastern EU/EEA countries. In 2015, compared with younger individuals, older adults were more likely to originate from the reporting country, to have acquired HIV via heterosexual contact, and to present late. Over time there were significant increases in HIV diagnoses in older men, women, men who have sex with men, and injecting drug users (annual average change, 2.2, 1.3, 5.8, and 7.4 percent, respectively).

"There is a compelling need to deliver more targeted testing interventions for older adults and the general adult population," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »